embryonic stem cell

Genomic instability in human pluripotent stem cells derivatives

by Alexey Bersenev on January 25, 2012 · 0 comments

in embryonic/iPS

Derivation and banking of clinical-grade embryonic stem cell lines

by Alexey Bersenev on December 7, 2011 · 1 comment

in embryonic/iPS

Ian Wilmut on the future of iPS cells, reprogramming and direct transdifferentiation

by Alexey Bersenev on December 5, 2011 · 0 comments

in direct reprogramming,embryonic/iPS

The pattern of genetic alterations in cultured human pluripotent stem cells

by Alexey Bersenev on November 29, 2011 · 0 comments

in embryonic/iPS

Geron went out of stem cell business

by Alexey Bersenev on November 14, 2011 · 1 comment

in cell product,notes

EU court bans embryonic stem cell-based patents – An update

by Alexey Bersenev on October 25, 2011 · 0 comments

in embryonic/iPS

EU court bans embryonic stem cell-based patents

by Alexey Bersenev on October 18, 2011 · 0 comments

in embryonic/iPS,events,web tools

Methods and protocols digest: iPS cells – part 1

by Alexey Bersenev on October 16, 2011 · 0 comments

in embryonic/iPS,methods,protocols

Lecture: Tim Kamp – Human pluripotent stem cells: tools for cardiovascular medicine

by Alexey Bersenev on September 22, 2011 · 0 comments

in lectures

Direct comparison of human pluripotent stem cell derivatives with tissue-derived counterparts

by Alexey Bersenev on September 12, 2011

in embryonic/iPS

← Previous Entries